Neutrophil cell death, activation and bacterial infection in cystic fibrosis

Thorax

Volumn 60, Issue 8, 2005, Pages 659-664

  Watt, A P ^a   Courtney, J ^a   Moore, J ^b   Ennis, M ^a   Elborn, J S ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 5; PROPIDIUM IODIDE;

ADULT; APOPTOSIS; ARTICLE; BACTERIAL INFECTION; BURKHOLDERIA CEPACIA; CELL ACTIVATION; CELL DEATH; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FLOW CYTOMETRY; GRAM NEGATIVE INFECTION; HUMAN; MALE; NEUTROPHIL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPUTUM CYTODIAGNOSIS;

ADULT; APOPTOSIS; BACTERIAL INFECTIONS; C-REACTIVE PROTEIN; CELL DEATH; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEMALE; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOCYTE ELASTASE; LYMPHOCYTE ACTIVATION; MALE; NEUTROPHILS; SPUTUM; VITAL CAPACITY;

EID: 23744490412     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2004.038240     Document Type: Article

References (41)

1. Tomlin KL, Coll OP, Ceri H. Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia. Can J Microbiol 2001;47:949-54.
2. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002;15:194-222.
3. Frangolias DD, Mahenthiralingam E, Rae S, et al. Burkholderia cepacia in cystic fibrosis. Variable disease course. Am J Respir Crit Care Med 1999;160:1572-7.
4. Nelson JW, Butler SL, Krieg D, et al. Virulence factors of Burkholderia cepacia. FEMS Immunol Med Microbiol 1994;8:89-97.
5. Straus DC, Lonon MK, Woods DE, et al. Production of an extracellular toxic complex by various strains of Pseudomonas cepacia. J Med Microbiol 1989;30:17-22.
6. Stover GB, Drake DR, Montie TC. Virulence of different Pseudomonas species in a burned mouse model: tissue colonization by Pseudomonas cepacia. Infect Immun 1983;41:1099-104.
7. Hammerle AF, Tatschl C, Jatzko S, et al. The lung as an inflammatory organ. Acta Anaesthesiol Scand Suppl 1997;111:59-64.
8. Henson PM. Possible roles for apoptosis and apoptotic cell recognition in inflammation and fibrosis. Am J Respir Cell Mol Biol 2003;29(3 Suppl):S70-6.
9. Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 1999;160:S5-11.
10. Lee A, Whyte MK, Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 1993;54:283-8.
11. Zychlinsky A, Sansonetti PJ. Apoptosis as a proinflammatory event: what can we learn from bacteria-induced cell death? Trends Microbiol 1997;5:201-4.
12. Usher LR, Lawson RA, Geary I, et al. Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J Immunol 2002;168:1861-8.
13. Hutchison ML, Poxton IR, Govan JR. Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect Immun 1998;66:2033-9.
14. Dacheux D, Toussaint B, Richard M, et al. Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils. Infect Immun 2000;68:2916-24.
15. Hendry J, Elborn JS, Nixon L, et al. Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa. Eur Respir J 1999;14:435-8.
16. Pavord ID, Pizzichini MM, Pizzichini E, et al. The use of induced sputum to investigate airway inflammation. Thorax 1997;52:498-501.
17. Kelly MG, Brown V, Martin SL, et al. Comparison of sputum induction using high-output and low-output ultrasonic nebulizers in normal subjects and patients with COPD. Chest 2002;122:955-9.
18. Castillo MJ, Nakajima K, Zimmerman M, et al. Sensitive substrates for human leukocyte and porcine pancreatic elastase: a study of the merits of various chromophoric and fluorogenic leaving groups in assays for serine proteases. Anal Biochem 1979;99:53-64.
19. United Kingdom Cystic Fibrosis Trust. Antibiotic treatment for cystic fibrosis. Bromley, Kent, 2000.
20. Watt AP, Brown V, Courtney J, et al. Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis. Thorax 2004;59:231-6.
21. Zhang X, Moilanen E, Kankaanranta H. Beclomethasone, budesonide and fluticasone propionate inhibit human neutrophil apoptosis. Eur J Pharmacol 2001;431:365-71.
22. Chilvers ER, Cadwallader KA, Reed BJ, et al. The function and fate of neutrophils at the inflamed site: prospects for therapeutic intervention. J R Coll Physicians Lond 2000;34:68-74.
23. Willingham MC. Cytochemical methods for the detection of apoptosis. J Histochem Cytol 1999;47:1101-9.
24. Steensma DP, Timm M, Witzig TE. Flow cytometric methods for detection and quantification of apoptosis. Methods Mol Med 2003;85:323-32.
25. Doring G. Cystic fibrosis respiratory infections: interactions between bacteria and host defence. Monaldi Arch Chest Dis 1997;52:363-6.
26. Vandivier RW, Fadok VA, Hoffmann PR, et al. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest 2002;109:661-70.
27. Kettritz R, Gaido ML, Haller H, et al. Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int 1998;53:84-91.
28. Fadok VA. Clearance: the last and often forgotten stage of apoptosis. J Mammary Gland Biol Neoplasia 1999;4:203-11.
29. Martin SJ, Reutelingsperger CP, McGahon AJ, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995;182:1545-56.
30. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 1995;182:1597-601.
31. Fadok VA, Bratton DL, Rose DM, et al. A receptor for phosphatidylserine- specific clearance of apoptotic cells. Nature 2000;405:85-90.
32. Kerby GS, Cottin V, Accurso FJ, et al. Impairment of macrophage survival by NaCl: implications for early pulmonary inflammation in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2002;283:L188-97.
33. Skubitz KM, Campbell KD, Skubitz AP. CD66a, CD66b, CD66c, and CD66d each independently stimulate neutrophils. Leukoc Biol 1996;60:106-17.
34. Kinhult J, Egesten A, Benson M, et al. Increased expression of surface activation markers on neutrophils following migration into the nasal lumen. Clin Exp Allergy 2003;33:1141-6.
35. Konstan MW, Berger M. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol 1997;24:137-42.
36. Bonfield TL, Panuska JR, Konstan MW, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995;152:2111-8.
37. Bonfield TL, Konstan MW, Berger M. Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol 1999;104:72-8.
38. Pukhalsky AL, Kapranov NI, Kalashnikova EA, et al. Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection. Mediators Inflamm 1999;8:159-67.
39. Takanashi S, Hasegawa Y, Kanehira Y, et al. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir J 1999;14:309-14.
40. Fink J, Steer JH, Joyce DA, et al. Pro-inflammatory effects of Burkholderia cepacia on cystic fibrosis respiratory epithelium. FEMS Immunol Med Microbiol 2003;38:273-82.
41. Becker MN, Sauer MS, Muhlebach MS, et al. Cytokine secretion by cystic fibrosis airway epithelial cells. Am J Respir Crit Care Med 2004;169:645-53.